dapsone has been researched along with etretinate in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bingham, EA; Burrows, D; Todd, DJ; Walsh, M | 1 |
Burg, G; Hartmann, AA; Miller, K; Zillikens, D | 1 |
Edmüller, M; Lubach, D; Rahm-Hoffmann, AL | 1 |
Camisa, C; Panzarella, K | 1 |
Hashimoto, T; Itoh, K; Kobayashi, H; Nakamura, J; Yamane, M; Yasuda, H | 1 |
Bruijnzeel, PL; Elliott, GR; Gijbels, MJ; HogenEsch, H; van den Hoven, A; Zurcher, C | 1 |
Albès, B; Bayle, P; Bazex, J; Carrière, M; Lamant, L; Launay, F | 1 |
1 review(s) available for dapsone and etretinate
Article | Year |
---|---|
Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin-1 and clinical review.
Topics: Adult; Anti-Infective Agents; Autoantibodies; Dapsone; Desmocollins; DNA, Complementary; Drug Therapy, Combination; Etretinate; Fluorescent Antibody Technique, Direct; Humans; Immunoglobulin A; Keratolytic Agents; Male; Membrane Glycoproteins; Pemphigus; Transfection | 2000 |
8 other study(ies) available for dapsone and etretinate
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Subcorneal pustular dermatosis and IgA paraproteinaemia: response to both etretinate and PUVA.
Topics: Aged; Dapsone; Diabetes Mellitus, Type 2; Etretinate; Humans; Immunoglobulin A; Male; Paraproteinemias; PUVA Therapy; Skin; Skin Diseases, Vesiculobullous | 1991 |
IgA pemphigus foliaceus: a case report.
Topics: Aged; Aged, 80 and over; Dapsone; Drug Therapy, Combination; Etretinate; Humans; Immunoglobulin A; Male; Pemphigus; Skin | 1990 |
[Combined retinoid and UV-phototherapy in pustulosis subcornealis (Sneddon-Wilkinson)].
Topics: Adult; Dapsone; Etretinate; Humans; Male; Photochemotherapy; Skin; Skin Diseases, Vesiculobullous; Tretinoin | 1980 |
Coexistence of superficial pemphigus and psoriasis.
Topics: Anti-Inflammatory Agents; Antigenic Modulation; Autoimmune Diseases; Dapsone; Erythema; Etretinate; Female; Glucocorticoids; Humans; Keratolytic Agents; Middle Aged; Pemphigus; Plasminogen Activators; Prednisone; Psoriasis; T-Lymphocytes | 1996 |
Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm).
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipruritics; Calcitriol; Capsaicin; Cell Division; Chronic Disease; Dapsone; Dermatitis; Etretinate; Keratolytic Agents; Loratadine; Mice; Mice, Inbred C57BL; Mutation | 2000 |
[Sneddon-Wilkinson disease. Four cases report].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Etretinate; Female; Humans; Immunoglobulin A; Keratolytic Agents; Male; Middle Aged; Paraproteinemias; Skin Diseases, Vesiculobullous; Treatment Outcome | 2004 |